ENO2 and laryngotracheoesophageal cleft: To determine the reactivity of a single marker, ten TAAs (CYFR21, CEA, NSE, SCC, CA15-3, CA 19-9, CA 125, CA50, CA242, and CA724) were measured from 132 LC patients and 118 BLD controls.